Table 4.

Association of rs2383206 genotype with extent, severity, and location of CAD in the incident event (population sets 1A and 1B) and the prevalent disease patients (sets 2A and 2B, excluding the non-CAD patients).

CAD Measure	AA	AG	GG	p-trend
Number of diseased vessels (mean)
Set 1A	1.94	1.95	2.02	0.15
Set 1B	1.88	1.83	1.89	0.87
Set 2A	1.79	1.70	1.78	0.87
Set 2B	1.74	1.72	1.78	0.57
Duke CAD Index (mean)
Set 1A	46.4	47.0	48.5	0.10
Set 1B	47.5	45.8	46.8	0.75
Set 2A	44.7	43.8	45.4	0.42
Set 2B	43.0	43.8	44.8	0.32
Left Main disease
Set 1A	3.6%	3.5%	2.3%	0.26
Set 1B	5.3%	6.2%	7.3%	0.36
Set 2A	1.4%	2.9%	2.6%	0.49
Set 2B	3.3%	5.2%	6.1%	0.20
Proximal disease
Set 1A	31.3%	35.6%	32.5%	0.86
Set 1B	47.1%	37.7%	39.7%	0.12
Set 2A	35.9%	34.9%	42.9%	0.06
Set 2B	40.6%	31.8%	38.9%	0.98
Ostial disease
Set 1A	5.3%	6.5%	5.5%	0.99
Set 1B	7.1%	7.7%	7.3%	0.95
Set 2A	2.4%	4.5%	6.1%	0.048
Set 2B	3.9%	5.0%	6.1%	0.29